Cystein proteinase inhibitor stefin A as an indicator of efficiency of tumor treatment in mice

Bulletin of Experimental Biology and Medicine

Volumn 136, Issue 1, 2003, Pages 46-48

  Korolenko, T A ^a   Poteryaeva, O N ^a   Falameeva, O V ^a   Levina, O A ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Antitumor therapy; Human stefin A; Mouse cystatin A; Mouse tumors

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 1,3 GLUCAN; BIOCHEMICAL MARKER; CYCLOPHOSPHAMIDE; CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR; STEFIN A; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; LEWIS CARCINOMA; LIVER; LIVER CELL CARCINOMA; LYMPHOSARCOMA; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SINGLE DRUG DOSE; SPLEEN; TISSUE LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; CARCINOMA, LEWIS LUNG; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; NEOPLASM TRANSPLANTATION; NEOPLASMS; SPLEEN; TIME FACTORS;

ANIMALIA;

EID: 0346639171     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026084712399     Document Type: Article

References (15)

1. O. N. Poteryaeva, O. V. Falameeva, S. Ya. Zhanaeva, et al., Byull. Eksp. Biol. Med., 132, No. 7, 77-79 (2001).
2. T. A. Korolenko, S. Ya. Zhanaeva, O. N. Poteryaeva, et al., Ibid., 133, No. 4, 452-455 (2002).
3. M. Budihna, R. Strojan, L. Smid, et al., Biol. Chem. Hoppe-Seyler, 377, No. 6, 385-390 (1996).
4. E. Ebert, B. Werle, B. Julke, et al., Adv. Exp. Med. Biol., 421, 259-265 (1997).
5. K. Hakansson, C. Huh, A. Grubb, et al., Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 114, No. 3, 303-311 (1996).
6. K. Hibbetts, B. Hines, and D. Williams, J. Vet. Intern. Med., 13, No. 4, 302-308 (1999).
7. G. Kogan, J. Sandula, T. A. Korolenko, et al., Int. Immunopharmacol., 2, 775-781 (2002).
8. J. Kos and T. T. Lah, Oncol. Rep., 5, 1349-1361 (1998).
9. J. Kos, B. Werle, T. Lah, and N. Brunner, Int. J. Biol. Markers, 15, 84-89 (2000).
10. J. Kos, M. Krasovec, N. Cimerman, et al., Clin. Cancer Res., 6, 505-511 (2000).
11. A. Russo, V. Bazan, M. Migliavcca, et al., Ibid., 6, No. 1, 178-184 (2000).
12. P. Strojan, M. Budihna, L. Smid, et al., Ibid., 6, 1052-1062 (2000).
13. T. Strojnik, I. Zajk, A. Bervar, et al., Pflugers Arch., 439, 122-123 (2000).
14. F. M. Tsui, H. W. Tsui, S. Mok, et al., Genomics, 15, 507-514 (1993).
15. B. Turk, V. Turk, and D. Turk, Biol. Chem., 378, 141-150 (1997).